Unlock the power of molecular data without the complexity

Our BioIntelligence platform transforms raw molecular data into actionable insights, bridging the gap between discovery and innovation.

Our roadmap

Our development journey

Here’s how we’re making it happen

Phase 1: Foundation and AI core (complete)

Harnessing publicly available datasets and building the core data platform

  • Integrated publicly available transcriptomic datasets to establish a strong foundation.
  • Developed an AI-powered core data platform to turn molecular data into actionable insights.
  • Established the core data infrastructure to support future datasets.

Phase 2: Expanding de novo data acquisition  (in progress)

Building the world’s largest high-quality transcriptomic dataset on skin

  • Conducting high-quality clinical studies with our Harpera microbiopsy technology to generate diverse, molecular datasets that contribute to our repository.
  • Expanding data coverage across different ethnicities, skin types and conditions, and global populations.
  • Structuring data to seamlessly integrate with our core data platform.
  • Establish key partnerships centered around on a shared vision of high-precision digital twins for dermatology.

Phase 3: Collaboration and workflow integration

Enabling seamless scientific collaboration

  • Developing an intuitive, end-to-end workflow layer to allow researchers to collaborate, share insights, and run analyses in real time.
  • Integrating customizable dashboards and automated reporting to simplify complex data exploration.
  • Ensuring secure, scalable, and user-friendly access for scientists, researchers, and industry partners alike.

Phase 4: Predictive modeling and AI refinement

Training AI to accelerate discovery and innovation

  • Building next-generation predictive models to forecast drug interactions, biomarker relevance, and clinical outcomes.
    • Focus 1: skin condition modeling - atopic dermatitis, psoriasis, skin-tropic infections etc.
    • Focus 2: an interventional model for healthy skin of various types.
  • Continuously refining AI algorithms with growing datasets, improving accuracy and insight depth.
  • Initiating discussions with regulators for registration of digital twin methodologies for drug and diagnostic discovery.
Our platform

A research team in your pocket

Whether you're exploring drug discovery, optimizing clinical trials, or mapping biological pathways, our AI-powered tools make it seamless.

01

AI-driven data insights

Automate complex analysis and reveal hidden patterns in molecular datasets.

02

Advanced data visualization

Intuitive, interactive dashboards make it easy to explore gene expression, pathways, and trial outcomes.

03

Seamless integration

Combining public datasets and proprietary research, enabling deeper insights without siloed data.

04

AI-powered research team

Expert-level insights across bioinformatics, molecular biology, and clinical research through conversational AI designed to support every stage of discovery.

Our partners

Designed for innovators

We empower pharma, biotech, and consumer health teams to unlock value from data.

  • Pharma R&D teams - Faster drug development, precision insights

  • Biotech and skin science innovators - Deep molecular data for breakthrough discoveries

  • Consumer health and personal care brands - Personalized product innovation and testing

Changing the game

Ready to accelerate your innovation?

From drug development to clinical trials and personal care innovation, Molecular Twins empowers your team to drive breakthroughs.